The Return to a Traditional Workplace May Be Inevitable This Year According to Recent Survey

Published on :

The Return to a Traditional Workplace May Be Inevitable This Year According Recent Survey
A recent ResumeBuilder.com survey may indicated a shift in the hiring strategy for most employers this year to replenish the traditional workplace.
Chris Frew, CEO at Workforce Genetics
As the world continues to navigate the aftermath of the pandemic, many companies are re-evaluating their approach to work in 2023, and the role of the office has returned as an important part of their operational strategy. A recent ResumeBuilder.com survey found that 90% of Companies Will Require Employees to Return to a Traditional Workplace this year.
This shift back towards in-person collaboration and connection is an indication of the growing realization of the benefits that come with traditional working environments – for both employers and employees.
The survey, which received feedback from 1,000 employers of companies that have been in business for at least three years and had a majority of workers in traditional office spaces prior to the pandemic, revealed some interesting findings. Currently, 66% of employers require employees to work from the office with some frequency. In the next six months, 73% of fully remote companies will return to in-person work, indicating that by 2023,…

Maryland Has 2nd Highest Percentage of Life Scientists vs. All Other Occupations

Published on :

Life Scientists as a Percentage of All Occupations
This indicator represents the percentage of life scientists in a state’s workforce. Life scientists are identified from standard occupational codes that include agricultural and food scientists, biological scientists, conservation scientists and foresters, medical scientists, and postsecondary teachers in these fields. A high share of life scientists in a state’s workforce could indicate a robust cluster of life sciences industries such as pharmaceutical and medicine manufacturing. States in the top quartile for this indicator also tend to contain agriculture-intensive industries.

Catalent Pharma Solutions In-Person Hiring Event

Published on :

Catalent is hiring across our Gene Therapy sites in Maryland! At Harman’s, we have a state-of-the-art cGMP, clinical through commercial gene therapy manufacturing facility. We are located just 5 miles [….]

CATALENT PHARMA SOLUTIONS IN-PERSON HIRING EVENT

Published on :

Catalent is hiring across our Gene Therapy sites in Maryland! At Harman’s, we have a state-of-the-art cGMP, clinical through commercial gene therapy manufacturing facility. We are located just 5 miles [….]

Global Cell and Gene Therapy Company Miltenyi Biotec is Expanding its Operations in Maryland 

Published on :

BALTIMORE, MD (March 15, 2022) — Global biotechnology business Miltenyi Biotec is expanding its operations in Maryland and transferring its North American headquarters to Gaithersburg. The company is working on expanding its 1201 Clopper Road facility to support additional manufacturing, research and development, quality assurance, and more. Miltenyi Biotec plans to add 130 new full-time jobs in Maryland, giving it a total of 300 employees in the state by the end of the year.
“By selecting Maryland for its North American headquarters, Miltenyi Biotec will help us continue growing our industry and further our efforts in remaining one of the top 10 life sciences clusters in the nation,” said Governor Larry Hogan. “We welcome the company’s continued investment in Montgomery County and look forward to supporting their efforts in Maryland and across the globe.”
This is not the company’s first investment in Maryland in recent years. In 2014, Miltenyi Biotec acquired Gaithersburg’s lentiviral vector manufacturing company Lentigen Technology Inc., which develops and commercializes therapeutics for stem cell therapies and oncology. In 2017, the company acquired Living Pharma, Inc., a startup of the University of Maryland, Baltimore that develops personalized cell therapy for targeted individuals’ cancers and diseases. Both became part…

An Employee-Centric Culture of Excellence has Helped CRB to Hire Nearly 50 New Employees

Published on :

CRB, a global architecture, engineering, construction (AEC) and consulting firm, with a major office in Rockville, Maryland, has been on the cutting edge of the biotechnology real estate business for over 35 years. Established in 2014 with just 8 people, over the past 2 years CRB’s Rockville office has grown from 50 employees to over 90, says Ben Skowronski, office lead. And they are still growing!

Biohealth Industry Day Highlights Partnerships and Pathways for Early-Career Professionals

Published on :

While the pandemic has forced many industries to downsize, biotech companies have had the opportunity — or sometimes the obligation — to ramp up. Just take a look at Catalent Pharma Solutions, the Baltimore-based contract manufacturer. The company has hired over 500 new employees since last March, said Talent Acquisition Specialist Charle’ Lamb during a panel at the Biohealth Industry Day.

Seraxis Eyes the Clinic Following $40 Million Capital Raise

Seraxis cell therapy replaces damaged or lost insulin-producing pancreatic cells
Published on :

Seraxis, which is currently located at the Pinkney Innovation Complex for Science & Technology at Montgomery College (PIC MC) in the County-owned Germantown Innovation Center is developing its lead therapy, SR-01, to eliminate the need for type 1 diabetes patients to inject insulin. SR-01 is a revolutionary therapy that could impact more than 4.5 million people in the world.

Emergent Biosolutions Seeks New Talent to Support Global COVID-19 Vaccination Push, Expanding Project Portfolio

Published on :

Maryland’s leading vaccine manufacturer, Emergent Biosolutions (Emergent), is a critical cog in the vaccine manufacturing and distribution engine as it has multiple COVID-19 vaccine manufacturing partnerships, including partnerships with J&J and AstraZeneca, among others. Emergent also partners with the Biomedical Advanced Research and Development Authority (BARDA), which provided approximately $628.3M in funding to the company as part of Operation Warp Speed.